FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure GHK Cu FDA Approval Status 2026: Not Approved January 2026 FDA New Drug Approvals Zycubo (copper histidinate) Some approvals mark progress. Others redefine what hope looks like. In January 2026, the U.S. FDA approved Zycubo (copper histidinate injection formerly GHK Cu [50mg] Elixser Peptides GHK Cu (Copper Peptide) Provider Supervised Therapy IV Glow Bar RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion